- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Tinea Faciei
An eruption on the face of a 49-year-old woman had been misdiagnosed as a staphylococcal infection; the rash failed to respond to oral and topical antibiotics. A mid-potency topical corticosteroid also had been tried, but the eruption worsened.
An eruption on the face of a 49-year-old woman had been misdiagnosed as a staphylococcal infection; the rash failed to respond to oral and topical antibiotics. A mid-potency topical corticosteroid also had been tried, but the eruption worsened.
A well-demarcated, annular, erythematous plaque with a raised border was noted. A potassium hydroxide preparation of a scraping from the border of the lesion confirmed the clinical impression of tinea faciei. The patient's new kitten was the suspected source of the dermatophyte.
A 2-week course of oral terbinafine, 250 mg/d, and twice-daily application of econazole cream were prescribed. The infection resolved within 3 weeks. The kitten was evaluated and treated by a veterinarian for a fungal infection. Pets are a common source of dermatophytes; treating their infection reduces the likelihood of reinfection.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
